Ambeed.cn

首页 / / / / 25-Hydroxycholesterol/25-羟基胆固醇

25-Hydroxycholesterol/25-羟基胆固醇 {[allProObj[0].p_purity_real_show]}

货号:A1251571 同义名: 25-OHC

25-Hydroxycholesterol是一种有效且选择性抑制 B 细胞 IgA 生成的化合物,EC50 约为 65 nM。

25-Hydroxycholesterol/25-羟基胆固醇 化学结构 CAS号:2140-46-7
25-Hydroxycholesterol/25-羟基胆固醇 化学结构
CAS号:2140-46-7
25-Hydroxycholesterol/25-羟基胆固醇 3D分子结构
CAS号:2140-46-7
25-Hydroxycholesterol/25-羟基胆固醇 化学结构 CAS号:2140-46-7
25-Hydroxycholesterol/25-羟基胆固醇 3D分子结构 CAS号:2140-46-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

25-Hydroxycholesterol/25-羟基胆固醇 纯度/质量文件 产品仅供科研

货号:A1251571 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

25-Hydroxycholesterol/25-羟基胆固醇 生物活性

描述 The synthesis of 25-Hydroxycholesterol is catalysed by cholesterol 25-hydroxylase, which uses cholesterol and molecular oxygen as substrates and NADPH as a cofactor. 25-Hydroxycholesterol is a potent biologically active lipid in the innate and adaptive immune system[1].

25-Hydroxycholesterol/25-羟基胆固醇 细胞实验

Cell Line
Concentration Treated Time Description References
HEK293T cells 1µM 8h Inhibited VSV-GFP expression Immunity. 2013 Jan 24;38(1):92-105
Bovine aortic smooth muscle cells (BASMC) 1 μg/ml 24 days 25-Hydroxycholesterol did not induce nodule formation or calcification in BASMC. J Clin Invest. 1994 May;93(5):2106-13
Bovine aortic endothelial cells (BAEC) 1 μg/ml 24 days 25-Hydroxycholesterol did not induce nodule formation or calcification in BAEC. J Clin Invest. 1994 May;93(5):2106-13
Calcifying vascular cells (CVC) 1 μg/ml 24 days 25-Hydroxycholesterol significantly increased the number of mineralized nodules formed by CVC, which were highly calcified. J Clin Invest. 1994 May;93(5):2106-13
PBMCs (Peripheral Blood Mononuclear Cells) 0.5 or 1.0 μM 12 h To evaluate the inhibitory effect of 25-HC@DDAB on cytokine storm in PBMCs from COVID-19 patients. Results showed that 25-HC@DDAB significantly reduced levels of inflammatory cytokines such as IL-1β. Nano Today. 2021 Jun;38:101149
BM-derived macrophages (BMDM) 25 ng/ml 4 h To study the effect of 25-HC on lipid body formation, results showed that 25-HC induces lipid body formation. J Exp Med. 2012 Apr 9;209(4):807-17
Caco2 cells 0.07 to 16.7 µM 20 h Evaluate the inhibitory effect of 25HC and 27HC on HRV infection, results showed both significantly inhibited HRV infection. Redox Biol. 2018 Oct;19:318-330
MA104 cells 0.07 to 16.7 µM 20 h Evaluate the inhibitory effect of 25HC and 27HC on HRV infection, results showed both significantly inhibited HRV infection. Redox Biol. 2018 Oct;19:318-330
splenic B220+ cells 250 nM 6 days 25-Hydroxycholesterol suppressed IgA class switch recombination in B cells, particularly when exposed early Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16764-9
bone marrow-derived macrophages 500 nM 24 h TLR4 activation led to significant increases in 25-hydroxycholesterol and CH25H mRNA and protein levels Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16764-9
apoE4-expressing microglia 10 μg/ml 24 h apoE4-expressing microglia secrete higher levels of IL-1β after treatment with LPS and 25-HC J Neuroinflammation. 2020 Jun 17;17(1):192
Primary mouse microglia (PMG) 5 μg/ml 24 h To investigate the effect of 25HC on microglial phagocytic capacity, results showed that 25HC significantly reduced the phagocytic ability of microglia. J Neuroinflammation. 2025 Feb 25;22(1):50
CEM cells 5µM 12h Inhibited HIV entry Immunity. 2013 Jan 24;38(1):92-105
HeLa cells 1µM 5h Inhibited Ebola virus replication Immunity. 2013 Jan 24;38(1):92-105
PBMCs 1µM 24h Inhibited HIV NL4-3 p24 expression Immunity. 2013 Jan 24;38(1):92-105
J2 BMMs 1µM 12h Reduced VSV replication Immunity. 2013 Jan 24;38(1):92-105
Bone marrow-derived macrophages (BMDMs) 1 μM 24 h To evaluate the effect of 25-HC on IL-1β production after L. monocytogenes infection. Results showed that Ch25h−/− BMDMs produced more IL-1β, and this effect was inhibited by the addition of 25-HC. Cell. 2017 Nov 16;171(5):1057-1071. e11

25-Hydroxycholesterol/25-羟基胆固醇 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Cecal ligation and puncture (CLP)-induced sepsis model Intravenous injection 1 μM Single dose, observed for 96 hours To evaluate the therapeutic effect of 25-HC@DDAB in a CLP-induced sepsis mouse model. Results showed that 25-HC@DDAB significantly improved survival rate (50%) and reduced inflammation and tissue damage. Nano Today. 2021 Jun;38:101149
Mouse 5XFAD transgenic mice Intraperitoneal injection 10 mg/kg Every other day for four weeks To investigate the effect of 25HC on Alzheimer's disease pathology, results showed that 25HC accelerated amyloid accumulation and exacerbated cognitive and behavioral deficits. J Neuroinflammation. 2025 Feb 25;22(1):50
C57BL/6 mice Myocardial ischemia-reperfusion injury model Intraperitoneal injection 10 mg/kg Single dose, 10 minutes before reperfusion 25-HC significantly reduced myocardial infarct size, improved cardiac function, and inhibited PARP activity. Int J Biol Sci. 2020 Jan 1;16(2):298-308
NRG-hu mice Humanized mouse model Intraperitoneal injection 50mg/kg Daily for 14 days Suppressed HIV replication and rescued T-cell depletion Immunity. 2013 Jan 24;38(1):92-105

25-Hydroxycholesterol/25-羟基胆固醇 参考文献

[1]McDonald JG, et al. Editorial: 25-Hydroxycholesterol: a new life in immunology. J Leukoc Biol. 2010 Dec;88(6):1071-2.

25-Hydroxycholesterol/25-羟基胆固醇 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.48mL

0.50mL

0.25mL

12.42mL

2.48mL

1.24mL

24.84mL

4.97mL

2.48mL

25-Hydroxycholesterol/25-羟基胆固醇 技术信息

CAS号2140-46-7
分子式C27H46O2
分子量 402.65
SMILES Code O[C@H](C1)CC[C@@]2(C)C1=CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@]4([H])[C@H](C)CCCC(O)(C)C
MDL No. MFCD00057815
别名 25-OHC
运输蓝冰
InChI Key INBGSXNNRGWLJU-ZHHJOTBYSA-N
Pubchem ID 65094
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 4 mg/mL(9.93 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

无水乙醇: 12 mg/mL(29.8 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。